Penobscot Investment Management Company Inc. Sells 8,029 Shares of Agilent Technologies, Inc. $A

Penobscot Investment Management Company Inc. decreased its position in Agilent Technologies, Inc. (NYSE:A) by 38.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,846 shares of the medical research company’s stock after selling 8,029 shares during the period. Penobscot Investment Management Company Inc.’s holdings in Agilent Technologies were worth $1,649,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Davis Capital Management bought a new position in shares of Agilent Technologies in the 3rd quarter worth about $28,000. Financiere des Professionnels Fonds d investissement inc. grew its stake in Agilent Technologies by 1.9% during the third quarter. Financiere des Professionnels Fonds d investissement inc. now owns 102,177 shares of the medical research company’s stock worth $13,114,000 after purchasing an additional 1,876 shares during the period. Signaturefd LLC increased its holdings in Agilent Technologies by 3.6% in the third quarter. Signaturefd LLC now owns 4,564 shares of the medical research company’s stock worth $586,000 after purchasing an additional 159 shares in the last quarter. SJS Investment Consulting Inc. increased its holdings in Agilent Technologies by 2,836.4% in the third quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after purchasing an additional 312 shares in the last quarter. Finally, Generali Asset Management SPA SGR lifted its stake in Agilent Technologies by 2.3% in the third quarter. Generali Asset Management SPA SGR now owns 42,331 shares of the medical research company’s stock valued at $5,433,000 after buying an additional 963 shares during the period.

Insider Buying and Selling at Agilent Technologies

In related news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the sale, the vice president directly owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 911 shares of Agilent Technologies stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the transaction, the chief executive officer directly owned 32,058 shares in the company, valued at $4,591,987.92. This represents a 2.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 16,401 shares of company stock valued at $2,468,962 in the last quarter.

Agilent Technologies Stock Up 1.3%

Shares of NYSE A opened at $137.82 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The company has a 50-day moving average price of $144.41 and a 200-day moving average price of $131.49. The stock has a market capitalization of $39.07 billion, a P/E ratio of 30.16, a P/E/G ratio of 4.00 and a beta of 1.29. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 0.7%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio is currently 21.66%.

Analyst Ratings Changes

Several analysts have recently commented on the stock. The Goldman Sachs Group started coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price objective for the company. Robert W. Baird raised their price target on shares of Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a report on Tuesday, November 25th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 price objective on the stock. Finally, Wells Fargo & Company raised their target price on Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $161.77.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.